Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2010
11/10/2010CN101375841B Daucane type sesquiterpenes and preparation method and application thereof
11/10/2010CN101342299B Medicament for preventing and controlling white diarrhea disease
11/10/2010CN101342275B Medicament for preventing and controlling aspergillus disease of chicken
11/10/2010CN101319011B Multi-type HCV-E1 epitope complex immunogen, encoding gene and application thereof
11/10/2010CN101314026B Serositis in duckling vaccine oral liquid synergistic agent for poultry biology and preparation method thereof
11/10/2010CN101293821B Compounds for inhibiting multi-medicine medicine-resistant staphylococcus aureus activity
11/10/2010CN101289455B Anti-influenza virus precursor drug and uses thereof
11/10/2010CN101279029B Liquid oral vaccine for curing blue-ear pig disease and method of preparing the same
11/10/2010CN101278998B Chinese medical tablets for curing non-symptom HIV infectious stage
11/10/2010CN101278923B Potassium sodium dehydroandroan drographolide succinate microcapsule and method for preparing injection thereof
11/10/2010CN101269164B Method of preparing virus bacterium blood serum Chinese aloe vaccine powder preparation and oral liquid for livestock, poultry biology and aquatic animal
11/10/2010CN101249160B Chinese medicine for curing hydrophobia
11/10/2010CN101244146B Method for preparing Chinese medicine injection for treating high-pathogenicity blue-ear disease of pig
11/10/2010CN101214295B Medicament for treating chicken infectivity laryngotracheitis
11/10/2010CN101186902B Pseudorabies virus SA215, pseudorabies virus polygene deletion bacterin and preparation method thereof
11/10/2010CN101185674B Infusion medicine for treating tinea pedis
11/10/2010CN101164572B Orally-administered medicine for treating hepatitis B virus
11/10/2010CN101138590B Use of medicinal fatheadtree leaf in the preparation of antimicrobial anti-inflammation medicament
11/10/2010CN101121922B Preparation method for wine brewing yeast cell culture secretion and use for the same in resisting DNA virus and promoting hepatocyte growth
11/10/2010CN101121701B Five-membered rings 3-position single-substituted benzosultam derivatives and preparation method thereof
11/10/2010CN101116670B Application of compound capable of providing active methyl or of taking part in the diversion of methyl in the preparation of medicine for treating virosis
11/10/2010CN101112464B Plaster for treating parotitis and the preparing method thereof
11/10/2010CN101104856B Series of non-viral vectors and pharmaceutical composition containing the same
11/10/2010CN101104637B Cecropin and its generation bacterial strain and use
11/10/2010CN101099566B Lactucin and its preparation method and application
11/10/2010CN101092456B Gene engineering antibody of human source neutrality for anti virus H5N1 of bird flu
11/10/2010CN101053597B Medicine for treating skin disease and beauty and preparation method thereof
11/10/2010CN101036784B Toxicity T cell position vaccine of the cell for treating Hepatitis B and the preparing method
11/10/2010CN101036679B Gynura procumbens chewing gums
11/10/2010CN101028513B Production for beach vibrio piscium efficient vaccine
11/09/2010US7829705 such as 7-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-4-ethoxy-cinnoline, used in the treatment of picornavirus infections in humans
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829683 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
11/09/2010US7829596 administering to the patient an effective amount of a xanthine oxidase inhibitor ( allopurinol, 7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, leukopterin, xanthopterin, neopterin etc.) to reduce sympathetic nervous system activity and/or improving cardiovascular reflex status for treating cachexia
11/09/2010US7829591 Nymphaeol-A, nymphaeol-B and nymphaeol-C; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829543 Substituted polyamines as inhibitors of bacterial efflux pumps
11/09/2010US7829524 nucleic acid constructs, vectors, and host cells; detergents; transgenic plants; animal feeds
11/09/2010US7829518 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
11/09/2010US7829124 administering an effective amount of an aqueous or alcohol extract of Phyllanthus to a mammal infected with the YMDD hepatitis B virus mutant strain resistant; inhibiting viral gene expression in a mammal infected with a hepatitis B virus
11/09/2010US7829103 immunogenic composition consisting of, as an active principle, a pure methylated heparin-binding hemagglutinin (HBHA) protein in a pharmaceutically acceptable formulation, and one or more adjuvants
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829079 Lactobacillus iners for the enhancement of urogenital health
11/09/2010CA2530140C Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
11/09/2010CA2479037C 2-amino-9[(2-hydroxymethyl)cyclopropylidenemethyl]purines as antiviral agents
11/09/2010CA2474563C Methods of inhibiting orthopoxvirus replication with nucleoside compounds
11/09/2010CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
11/09/2010CA2434028C Amino ceramide-like compounds and therapeutic methods of use
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/09/2010CA2342305C Pestivirus mutants and vaccines containing the same
11/09/2010CA2208420C Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/04/2010WO2010127363A1 Toposiomerase inhibitors
11/04/2010WO2010127360A1 Toposiomerase inhibitors
11/04/2010WO2010127307A1 Antimicrobial agents
11/04/2010WO2010127132A1 Inactivated bacterial cell formulation
11/04/2010WO2010126839A2 Processed feeds, foods and biofuels and methods of making and using them
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125524A1 A glutathione reductase-peg conjugate and the use thereof as an anti-influenza medicament
11/04/2010WO2010125162A1 Anti cxcr4 antibodies for the treatment of hiv
11/04/2010WO2010125082A1 Oxazole substituted indazoles as pi3-kinase inhibitors
11/04/2010WO2010124618A1 Use of cell autophagy (type ii cell apoptosis) inhibitors
11/04/2010WO2010124601A1 Method for producing injectable preparation containing ceftriaxone sodium and tazobactam sodium
11/04/2010WO2010124547A1 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
11/04/2010WO2010124520A1 Pharmaceutical composition for treating abnormal energy metabolism and use thereof
11/04/2010WO2010124377A1 Mutants of francisella tularensis and uses thereof
11/04/2010WO2010124373A1 Influenza vaccine
11/04/2010WO2010080188A3 Epitope targeted anthrax vaccine
11/04/2010WO2010077061A3 Pharmaceutical formulations containing antiviral drugs
11/04/2010WO2010075101A3 Treating picornavirus infection by targeting microrna mir-141
11/04/2010US20100281566 Transcriptional control element, chimeric consructs and uses therefor
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280229 Polypeptide
11/04/2010US20100280133 Aqueous emulsion containing a cyclodextrin derivative, a perfume, and a polysorbate
11/04/2010US20100280099 Combination Treatment For The Treatment of Hepatitis C Virus Infection
11/04/2010US20100280096 Treatment of influenza
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280065 Perharidines as cdk inhibitors
11/04/2010US20100280055 Flavoring Systems for Pharmaceutical Compositions and Methods of Making Such Compositions
11/04/2010US20100280053 CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist
11/04/2010US20100280052 Use of antivirals to treat cmv-related conditions
11/04/2010US20100280045 Novel compounds
11/04/2010US20100280036 Modulation of Pathogenicity
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280029 Novel compounds
11/04/2010US20100280027 Pharmaceutical compounds
11/04/2010US20100280022 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type
11/04/2010US20100280010 Chemical compounds
11/04/2010US20100280001 Imidazoquinolines with immuno-modulating properties
11/04/2010US20100279998 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors
11/04/2010US20100279994 Ansamycin Formulations and Methods of Use Thereof
11/04/2010US20100279983 Novel inhibitors of beta-lactamase
11/04/2010US20100279978 Methods of reducing the severity of mucositis
11/04/2010US20100279975 Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
11/04/2010US20100279974 Nucleosides With Non-Natural Bases as Anti-Viral Agents
1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 1798